WILMINGTON, Del., Nov. 4, 2014 /PRNewswire/ -- Rigrodsky &
Long, P.A. announces that it is investigating whether certain
officers and directors of Bio-Rad Laboratories, Inc. ("Bio-Rad" or
the "Company") (NYSE: BIO) breached their fiduciary duties to
shareholders.
On November 3, 2014, Bio-Rad
announced the full resolution of previously disclosed
investigations by the U.S. Department of Justice ("DOJ") and
Securities and Exchange Commission ("SEC") into past violations of
the Foreign Corrupt Practices Act ("FCPA") that occurred from 2005
to 2010 related to Thailand,
Vietnam, and Russia.
Although the DOJ declined to prosecute Bio-Rad, the parties
entered into a Non-Prosecution Agreement under which Bio-Rad has
agreed to pay a penalty of $14.35
million. Under the terms of the civil settlement with the
SEC, the Company will pay $40.7
million in disgorgement and prejudgment interest. The
Company has also agreed to certain future reporting, compliance and
self-monitoring provisions over the next two years.
If you own the common stock of Bio-Rad and would like to learn
more about the investigation, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2
Righter Parkway, Suite 120, Wilmington,
DE 19803, by telephone at (888) 969-4242; by e-mail to
info@rl-legal.com, or at:
http://www.rigrodskylong.com/investigations/bio-rad-laboratories-inc-bio.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes
securities class, derivative and direct actions, shareholder rights
litigation and corporate governance litigation, on behalf of
shareholders in states and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a
similar outcome.
CONTACT:
Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
http://www.rigrodskylong.com
SOURCE Rigrodsky & Long, P.A.